Rare Disease Trial, Recruiting NCT04604626 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT04604626
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 (Genetic obesity):

  • Adults aged 18 or older with a BMI over 35, OR children under 18 with a very high BMI for their age and sex, who are being seen at one of the participating clinics
  • Patients who are already receiving genetic testing as part of their normal medical care, because they have obesity that started before age 12, a very high BMI (over 50), unusual eating behaviours, hormone-related problems, or other signs that may suggest a genetic cause (such as intellectual disability or eye problems)
  • The patient themselves (if an adult), or a parent/guardian (if the patient is a child), must have received information about the study and signed a consent form agreeing to take part — or, for adults who cannot consent for themselves, their legal representative or a close person must have agreed on their behalf

Group 2 (Obesity caused by brain damage):

  • Adults or children who have obesity and/or eating disorders caused by damage to a part of the brain called the hypothalamus (for example, due to a tumour called a craniopharyngioma)
  • The patient themselves (if an adult), or a parent/guardian (if the patient is a child), must have received information about the study and signed a consent form — or, for adults who cannot consent for themselves, their legal representative or a close person must have agreed on their behalf

Who may not be able to join:

  • People who do not wish to take part in the study
  • People who do not speak or understand French
  • People excluded for safety reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: CHRISTINE POITOU-BERNERT, Professor, Assistance Publique - Hôpitaux de Paris

Phone: (33)1.42.17.57.71

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 June 2020
Est. completion
1 July 2022

Where this trial is recruiting

🇫🇷 France

Primary endpoints

This criterion is the age of obesity beginning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov